NATIXIS – Regeneron Pharmaceuticals, Inc. Transaction History
NATIXIS portfolio value:
$0
portfolio value
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | put | Decrease | -100.00% | -396 shares | -235K | $688.87 | 0 |
| Q3 2022 | share | Decrease | -42.81% | -21.27K shares | -9.70M | $688.87 | 28.42K |
| Q2 2022 | share | Decrease | -62.31% | -82.17K shares | -62.68M | $591.13 | 49.69K |
| Q2 2022 | put | Increase | 0.00% | 396 shares | 235K | $591.13 | 396 |
| Q1 2022 | share | Increase | +630.25% | 113.81K shares | 80.69M | $698.42 | 131.86K |
| Q4 2021 | share | Increase | +38.45% | 5.01K shares | 3.51M | $642.51 | 18.05K |
| Q3 2021 | share | Increase | 0.00% | 13.04K shares | 7.89M | $605.18 | 13.04K |
| Q2 2021 | share | Decrease | -100.00% | -26.72K shares | -12.64M | $558.54 | 0 |
| Q1 2021 | share | Increase | +5.39% | 1.36K shares | 395K | $473.14 | 26.72K |
| Q4 2020 | share | Increase | +147.34% | 15.10K shares | 6.51M | $483.11 | 25.35K |
| Q3 2020 | share | Decrease | -91.99% | -117.74K shares | -74.08M | $559.78 | 10.25K |
| Q2 2020 | share | Increase | +1327.56% | 119.02K shares | 75.44M | $623.65 | 127.99K |
| Q1 2020 | share | Increase | +56.58% | 3.24K shares | 2.23M | $488.29 | 8.96K |
| Q4 2019 | share | Increase | 0.00% | 5.72K shares | 2.14M | $375.48 | 5.72K |
| Q3 2019 | share | Decrease | -100.00% | -58.30K shares | -18.25M | $277.4 | 0 |
| Q2 2019 | share | Decrease | -0.24% | -140 shares | -5.41M | $313 | 58.30K |
| Q1 2019 | share | Increase | 0.00% | 58.44K shares | 23.66M | $410.62 | 58.44K |
| Q4 2018 | share | Decrease | -100.00% | -1.51K shares | -611K | $373.5 | 0 |
| Q3 2018 | share | Increase | 0.00% | 1.51K shares | 611K | $404.04 | 1.51K |
| Q1 2018 | share | Decrease | -100.00% | -4.89K shares | -1.84M | $344.36 | 0 |
| Q4 2017 | share | Decrease | -75.99% | -15.48K shares | -7.27M | $375.96 | 4.89K |
| Q3 2017 | share | Increase | 0.00% | 20.37K shares | 9.11M | $447.12 | 20.37K |
| Q2 2017 | share | Decrease | -100.00% | -3.29K shares | -1.27M | $491.14 | 0 |
| Q1 2017 | share | Decrease | -63.50% | -5.72K shares | -2.03M | $387.51 | 3.29K |
| Q4 2016 | share | Increase | 0.00% | 9.01K shares | 3.31M | $367.09 | 9.01K |